参考文献/References:
[1] KIM S H,LEE S H.Updates on ankylosing spondylitis:pathogenesis and therapeutic agents[J].J Rheum Dis,2023,30(4):220-233.
[2] 邹佳,尧章洪,郑其祥,等.盐酸小檗碱对芍药苷的经皮促透规律及促透机制研究[J].中草药,2023,54(22):7412-7420.
[3] 胡威,方满新,刘犇,等.小檗碱的生物学功能及其在动物生产中的应用[J].动物营养学报,2023,10(30):1-13.
[4] LI S,LIU X,CHEN X,et al.Research progress on anti-inflammatory effects and mechanisms of alkaloids from Chinese medical herbs[J].Evid Based Complement Alternat Med,2020,18:1303524.
[5] YANG F J,GAO R M,LUO X X,et al.Berberine influences multiple diseases by modifying gut microbiota[J].Front Nutr,2023,10:1187718.
[6] VAN DER LINDEN S,VALKENBURG H A,CATS A.Evaluation of diagnostic criteria for ankylosing spondylitis:a proposal for modification of the New York criteria[J].Arthritis Rheum,1984,27(4):361-368.
[7] BAETEN D,VAN DEN BOSCH F,ELEWAUT D,et al.Needle arthroscopy of the knee with synovial biopsy sampling:technical experience in 150 patients[J].Clin Rheumatol,1999,18(6):434-441.
[8] RAMIRO S,NIKIPHOROU E,SEPRIANO A,et al.ASAS-EULAR recommendations for the management of axial spondyloarthritis:2022 update[J].Ann Rheum Dis,2023,82(1):19-34.
[9] CHEN S,PAVELEY R,KRAAL L,et al.Selective targeting of PI3K δ suppresses human IL-17-producing T cells and innate-like lymphocytes and may be therapeutic for IL-17-mediated diseases[J].J Autoimmun,2020,111:102435.
[10] CHEN J,HUANG Y,BIAN X,et al.Berberine ameliorates inflammation in acute lung injury via NF-κB/NLRP3 signaling pathway[J].Front Nutr,2022,9:851255.
[11] ZHANG H,SHAN Y,WU Y,et al.Berberine suppresses LPS-induced inflammation through modulating Sirt1/NF-κB signaling pathway in RAW264.7 cells[J].Int Immunopharmacol,2017,52:93-100.
[12] LIAO H T,TSAI C Y.Cytokines and regulatory T cells in ankylosing spondylitis[J].Bone Joint Res,2023,12(2):133-137.
[13] 李家江,王守鹏,张兆川,等.微小RNA-146a靶向调控Krüppel样转录因子7对强直性脊柱炎T细胞炎症反应及自噬的影响[J].安徽医药,2022,26(8):1611-1614.
[14] VAN DER HEIJDE D,DEODHAR A,BARALIAKOS X,et al.Efficacy and safety of bimekizumab in axial spondyloarthritis:results of two parallel phase 3 randomised controlled trials[J].Ann Rheum Dis,2023,82(4):515-526.
[15] CAI L,ZHOU M Y,HU S,et al.Umbelliferone inhibits migration,invasion and inflammation of rheumatoid arthritis fibroblast-like synoviocytes and relieves adjuvant-induced arthritis in rats by blockade of Wnt/β-catenin signaling pathway[J].Am J Chin Med,2022,50(7):1945-1962.
[16] SUN Y,HUANG H,ZHAN Z,et al.Berberine inhibits glioma cell migration and invasion by suppressing TGF-β1/COL11A1 pathway[J].Biochem Biophys Res Commun,2022,625:38-45.
[17] HU Q,LI L,ZOU X,et al.Berberine attenuated proliferation,invasion and migration by targeting the AMPK/HNF4α/WNT5A pathway in gastric carcinoma[J].Front Pharmacol,2018,9:1150.
[18] 宗世烨,周静,蔡伟伟,等.小檗碱抑制类风湿关节炎患者的成纤维样滑膜细胞的自噬并促进其凋亡:基于下调ROS/mTOR信号通路[J].南方医科大学学报,2023,43(4):552-559.
[19] HUI W,ZHAO C,BOURGOIN S G.Differential effects of inhibitor combinations on lysophosphatidic acid-mediated chemokine secretion in unprimed and tumor necrosis factor-α-primed synovial fibroblasts[J].Front Pharmacol,2017,8:848.
[20] FARKHONDEH T,MEHRPOUR O,BUHRMANN C,et al.Organophosphorus compounds and MAPK signaling pathways[J].Int J Mol Sci,2020,21(12):4258.
[21] IJOMONE O M,IROEGBU J D,ASCHNER M,et al.Impact of environmental toxicants on p38-and ERK-MAPK signaling pathways in the central nervous system[J].Neurotoxicology,2021,86:166-171.
[22] ROVIDA E,TUSA I.Targeting MAPK in cancer 2.0[J].Int J Mol Sci,2022,23(10):5702.
[23] LI J Z,CHEN Z H,LIAO H,et al.Anti-osteogenic effect of Danshensu in ankylosing spondylitis:an in vitro study based on integrated network pharmacology[J].Front Pharmacol,2021,12:772190.
[24] SHARMA A R,JAGGA S,CHAKRABORTY C,et al.Fibroblast-like-synoviocytes mediate secretion of pro-inflammatory cytokines via ERK and JNK MAPKs in ti-particle-induced osteolysis[J].Materials(Basel),2020,13(16):3628.
[25] CZARNECKA A M,SYNORADZKI K,FIRLEJ W,et al.Molecular biology of osteosarcoma[J].Cancers(Basel),2020,12(8):2130.
[26] LEONE G M,MANGANO K,PETRALIA M C,et al.Past,present and(foreseeable)future of biological anti-TNF-α therapy[J].J Clin Med,2023,12(4):1630.